Think Research Corporation (THNK.V)
| Previous Close | 0.4750 |
| Open | 0.4550 |
| Bid | 0.4450 x N/A |
| Ask | 0.4550 x N/A |
| Day's Range | 0.4400 - 0.4550 |
| 52 Week Range | 0.4400 - 2.6300 |
| Volume | |
| Avg. Volume | 44,035 |
| Market Cap | 26.493M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5890 |
| Earnings Date | Aug 22, 2022 - Aug 26, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.01 |
- CNW Group
Think Research Signs 3-year SaaS Contract with Top U.S. Pharmacy Retailer
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that it has been contracted by a major U.S.-based pharmacy to deliver business intelligence and support solutions to more than 1700 pharmacies servicing 5.5 million patients throughout the United States. This contract is a direct result of the acquisition and subsequent integration of Pharmapod Ltd. ("Pharm
- CNW Group
Think Research Engages Oak Hill as an Investor Relations Advisor & Promoter
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a healthcare technology company focused on transforming healthcare through knowledge-based digital health software solutions, announced today that it has amended its existing advisory services agreement (the "Amended Services Agreement") with Oak Hill Financial Inc. ("Oak Hill"), following receipt of conditional approval of the TSX Venture Exchange ("TSXV").
- CNW Group
Think Research Announces Grant of Equity Compensation
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a company focused on transforming healthcare through integrated digital health software solutions, today announced that it has granted 261,955 restricted share units (each, an "RSU") to key employees of the Company pursuant to the Company's Omnibus Equity Incentive Plan which will vest immediately.
